Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland-Reference-Cited by-同舟云学术

Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland

Published:2021-04-09 Issue:3 Volume:188 Page:789-798
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

McSorley L. M.^ORCID,Tharmabala M.,Al Rahbi F.,McSorley K.,Chew S.,Evoy D.,Geraghty J. G.,Prichard R. S.,Rothwell J.,McCartan D. P.,McDermott E. W.,Keane M.,Kennedy M. J.,O’Reilly S.,Millen S. J.,Crown J. P.,Smyth L. M.,Kelly C. M.,Quinn C. M.,Walshe J. M.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-021-06211-w.pdf

Reference50 articles.

1. NCRI (2019) Cancer in Ireland 1994–2017 with estimates for 2017–2019: annual report of the National Cancer Registry. Cork, Ireland

2. NCRI (2019) Cancer Trends No. 37. Breast cancer 1994–2016. Cork, Ireland

3. Dignam JJ et al (2009) Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer. Breast Cancer Res Treat 116(3):595–602

4. Goldvaser H et al (2018) Absolute benefit from adjuvant chemotherapy in contemporary clinical trials: a systemic review and meta-analysis. Cancer Treat Rev 71:68–75

5. Fisher B et al (2004) Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project Clinical Trials. J Natl Cancer Inst 96(24):1823–1831

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing clinical decision support with genomic tools in breast cancer: A Scottish perspective;The Breast;2024-06

2. Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage Breast Carcinoma in Ireland;Current Oncology;2024-03-01

3. Decision impact studies, evidence of clinical utility for genomic assays in cancer: A scoping review;PLOS ONE;2023-03-10

4. Enhancing Clinical Decision Support with Genomic Tools in Breast Cancer: A Scottish Perspective;2023

5. Right Sizing Systemic Therapy for Patients with Breast Cancer. Where are we Today?;Current Breast Cancer Reports;2022-12